Literature DB >> 11134616

Valproate prevents the induction of sensitization to methylphenidate (ritalin) in rats.

P Yang1, A Beasley, K Eckermann, A Swann, N Dafny.   

Abstract

Repetitive exposure to methylphenidate (MPD) elicits sensitization to its locomotor effects. Drugs that affect the GABA system may modify adaptations to drug exposure. Therefore, we have examined the effect of sodium valproate, which enhances GABA function, on the development of sensitization to MPD using an automated, computerized animal activity monitoring system to record each rat's motor activities for 15 consecutive days. Rats were recorded before and after saline injection (Days 1-2) to provide baseline activity. Animals were then randomly assigned to the following three groups that received: (1) 2.5 mg/kg MPD (s.c.) for six consecutive days (Days 3-8), (2) a single dose of valproate (50 mg/kg; i.p.) 1 h prior to the first (Day 3) of six daily doses of MPD (2.5 mg/kg; s.c. ), or (3) five daily doses of valproate (50 mg/kg, i.p.) 1 h prior to MPD (2.5 mg/kg, s.c.) on Days 4-8. There was no drug treatment during the next 5 days (Days 9-13). All rats were then re-challenged with MPD (2.5 mg/kg, s.c.) on Day 14. Group 2 rats were also re-challenged with 50 mg/kg valproate followed by 2.5 mg/kg MPD 1 h later on Day 15. Administration of MPD alone produced a sensitized response. Multiple valproate injections prevented the induction of MPD-elicited sensitization in all four motor indices, while a single valproate injection prevented the induction of MPD-elicited sensitization in two of four motor indices studied. In conclusion, a single injection 50 mg/kg valproate given prior to any MPD treatment partially blocked the induction of MPD sensitization while repeated injections of valproate co-administered with MPD treatment completely prevented this effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11134616     DOI: 10.1016/s0006-8993(00)02996-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse.

Authors:  Nicole M Enman; Ellen M Unterwald
Journal:  Behav Brain Res       Date:  2012-05-16       Impact factor: 3.332

2.  Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.

Authors:  K Ito; T Abekawa; T Koyama
Journal:  Psychopharmacology (Berl)       Date:  2006-04-01       Impact factor: 4.530

3.  Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate.

Authors:  S J Wanchoo; M J Lee; A C Swann; N Dafny
Journal:  Brain Res       Date:  2009-11-22       Impact factor: 3.252

4.  Cocaine-induced hyperactivity and sensitization are dependent on GSK3.

Authors:  Jonathan S Miller; Ronald J Tallarida; Ellen M Unterwald
Journal:  Neuropharmacology       Date:  2009-03-27       Impact factor: 5.250

5.  Single exposure of dopamine D1 antagonist prevents and D2 antagonist attenuates methylphenidate effect.

Authors:  Catherine M Claussen; Lindsey J Witte; Nachum Dafny
Journal:  J Exp Pharmacol       Date:  2015-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.